Taro Pharmaceutical Industries Ltd. (TARO) Fundamentals

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
SHARE INFORMATION
Market Cap$ 1,174,143,872
Shares Outstanding37,584,631
Float8,086,818
Percent Float21.52%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 561,347,000
Latest Fiscal EPS$ 1.55
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions186
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months715,556
Institutional Holdings Percent17.2%
Institutional Sold Previous 3 Months1,100,765
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 65.21
52 Week Low$ 28.46
52 Week High Change$ -51.08
21 Day Moving Average$ 31.2805
21 Day Extended Moving Average$ 31.3036
50 Day Moving Average$ 33.1834
50 Day Extended Moving Average$ 32.98
200 Day Moving Average$ 40.1105
200 Day Extended Moving Average$ 40.8525
10 Day Average Volume18,163
20 Day Average Volume14,417
30 Day Average Volume16,480
50 Day Average Volume16,014
Alpha-0.021582
Beta0.6695
Standard Deviation0.077483
R20.203008
7 Day Price Change$ 0.66
7 Day Percent Change2.16%
21 Day Price Change$ -0.67
21 Day Percent Change-2.1%
30 Day Price Change$ -1.26
30 Day Percent Change-3.88%
Month to Date Price Change$ 1.26
Month to Date Percent Change4.2%
Quarter to Date Price Change$ 1.26
Quarter to Date Percent Change4.2%
180 Day Price Change$ -11.83
180 Day Percent Change-27.47%
200 Day Price Change$ -14.26
200 Day Percent Change-31.34%
Year to Date Price Change$ -18.87
Year to Date Percent Change-37.66%

Taro Pharmaceutical Industries Ltd. (TARO) Key Ratios

PROFITABILITY
EBIT Margin9.2%
EBITDA Margin13.9%
Pre-Tax Profit Margin26.4%
Profit Margin Count14.96%
Gross Margin52.0%
Profit Margin TOT14.96%
INCOME STATEMENTS
Revenue$ 438,913,000
Revenue Per Share$ 11.678
Revenue (3 Years)$ -11.60
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage71.30
Current Ratio3.60
Leverage Ratio1.30
Quick Ratio3.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio12.70
Enterprise Value$ 334,560,455
Price to Sales2.6751
Price to Free Cash-5.50
PE High Last 5 Years23.00
Price To Book0.70
Price To Cash Flow21.20
PE Low Last 5 Years-4.20
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.60
Invoice Turnover1.40
Assets Turnover0.20
Return Assets4.29
Return on Equity5.73
Return on Capital4.98

Taro Pharmaceutical Industries Ltd. (TARO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorZiv Haft Certified Public Accountants (Isr.)
CEOUday Baldota
Emplyoees1455
Last AuditUQ
CIK0000906338
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address14 Hakitor Street
P.O. Box 10347
Haifa, 2624761
Websitehttp://www.taro.com
Facsimile-
Telephone+972 48475700
EmailWilliam.Coote@taro.com
Your Recent History
NYSE
TARO
Taro Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221005 15:35:40